Juniper Investment Company, LLC
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Juniper Investment Company, LLC reported 10 stock positions worth $377.5 million. Its top holding was Lincoln Educational Services (LINC) at 22.9% of the portfolio, followed by Allient (ALNT, 20.8%) and Bioventus Class A (BVS, 17.4%). Compared with Q1 2026, it opened 2 new positions, added to 3 and reduced 2. The biggest buy was Lsi Industries (LYTS, shares +1%) and the biggest sale Lincoln Educational Services (LINC, shares −11%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001794034
- Portfolio Value
- $377.5M (Q2 2026)
- SEC Filing
- 0001214659-26-010370 ↗ filed Aug 14, 2026
Holdings Value
Holdings 10 stocks · $377.5M
| LINC Lincoln Educational Services | 22.91% | 1,732,966 | $86.5M | Reduce -10.6% |
| ALNT Allient Inc. | 20.79% | 762,305 | $78.5M | Reduce -4.2% |
| BVS Bioventus Inc. Class A | 17.35% | 6,939,357 | $65.5M | No change |
| AORT Artivion Inc. | 12.02% | 2,019,885 | $45.4M | Add +69.9% |
| OFIX Orthofix Medical Inc. | 10.76% | 4,442,543 | $40.6M | Add +11.7% |
| TWIN Twin Disc Inc. | 6.30% | 1,024,954 | $23.8M | No change |
| LYTS Lsi Industries Inc. | 5.50% | 781,399 | $20.8M | Add +1.4% |
| ALOT Astronova Inc. | 4.04% | 535,203 | $15.2M | No change |
| MG Mistras Group Inc. | 0.28% | 61,138 | $1.1M | New |
| BSX Boston Scientific Corp. | 0.05% | 4,100 | $175K | New |
Options reported separately and not counted above: BSX calls ($137K).
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
Options Activity Q1 2026 → Q2 2026
| BA The Boeing Co. | call | Sold out | 1,500 | $299Kbefore exit |
| BSX Boston Scientific Corp. | call | New | 3,200 | $137K |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $377.5M | LINC, ALNT, BVS, AORT, OFIX |
| Q1 2026 | 8 | $313.1M | LINC, BVS, ALNT, OFIX, AORT |
| Q4 2025 | 8 | $290.9M | LINC, AORT, OFIX, BVS, ALNT |
| Q3 2025 | 9 | $261.4M | AORT, LINC, BVS, OFIX, ALNT |
| Q2 2025 | 11 | $242.6M | AORT, LINC, BVS, ALNT, OFIX |
| Q1 2025 | 11 | $221.9M | BVS, AORT, LINC, OFIX, ALNT |
| Q4 2024 | 11 | $253.5M | BVS, AORT, LINC, OFIX, ALNT |
| Q3 2024 | 12 | $239.5M | BVS, AORT, LINC, ALNT, OFIX |
| Q2 2024 | 12 | $208.6M | AORT, LINC, BVS, VSEC, ALNT |
| Q1 2024 | 10 | $201.0M | AORT, BVS, LINC, VSEC, ALNT |